Literature DB >> 1643745

Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein.

M G Danieli1, D Markovits, A Gabrielli, A Corvetta, P L Giorgi, R van der Zee, J D van Embden, G Danieli, I R Cohen.   

Abstract

Immune reactivity to the 65-kDa mycobacterial heat shock protein (hsp65) has been associated with arthritis in rats and humans. In this report we evaluated patients with juvenile rheumatoid arthritis for such immunity. A high proportion of affected children showed both antibody and T lymphocyte responses to hsp65 and to two related peptides: the nonapeptide 180-188 sequence of hsp65 and a partially homologous peptide of the cartilage proteoglycan link protein. The titer of circulating antibodies was generally higher in patients with clinically active disease. In contrast to the juvenile rheumatoid arthritis patients, patients with adult rheumatoid arthritis tended to have lower responses of their peripheral blood T lymphocytes to the whole hsp65 molecule. Moreover, the adult rheumatoid arthritis patients did not respond to the peptides. Thus, there appear to be immunological differences between juvenile and adult forms of rheumatoid arthritis related to hsp65 reactivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643745     DOI: 10.1016/0090-1229(92)90189-u

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  11 in total

Review 1.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

2.  A novel atherogenic epitope from Mycobacterium tuberculosis heat shock protein 65 enhances atherosclerosis in rabbit and LDL receptor-deficient mice.

Authors:  Yu Zhang; Qiyan Xiong; Xiangbing Hu; Yunxiao Sun; Xiying Tan; Huiyong Zhang; Yong Lu; Jingjing Liu
Journal:  Heart Vessels       Date:  2011-10-29       Impact factor: 2.037

3.  Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis.

Authors:  M R al-Shamma; C McSharry; K McLeod; E A McCruden; B H Stack
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 4.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.

Authors:  R Rodrigues dos Santos Júnior; A Sartori; V L Deperon Bonato; A A M Coelho Castelo; C A Vilella; R L Zollner; C Lopes Silva
Journal:  Clin Exp Immunol       Date:  2007-06-22       Impact factor: 4.330

6.  Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.

Authors:  B Taşçi; H Direskeneli; P Serdaroglu; G Akman-Demir; M Eraksoy; G Saruhan-Direskeneli
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

7.  Green tea protects rats against autoimmune arthritis by modulating disease-related immune events.

Authors:  Hong Ro Kim; Rajesh Rajaiah; Qing-Li Wu; Shailesh R Satpute; Ming T Tan; James E Simon; Brian M Berman; Kamal D Moudgil
Journal:  J Nutr       Date:  2008-11       Impact factor: 4.798

8.  Immunomodulation of Autoimmune Arthritis by Herbal CAM.

Authors:  Shivaprasad H Venkatesha; Rajesh Rajaiah; Brian M Berman; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-22       Impact factor: 2.629

9.  Antibodies against M. Bovis 65 KDa Heat Shock Protein and Its P180-188 Epitope in Sera of Patients with Juvenile Idiopathic Arthritis.

Authors:  Denisa Zlacka; Jiri Velek; Pavla Vavrincova; Ilona Hromadnikova
Journal:  Int J Biomed Sci       Date:  2007-09

10.  HSP60: issues and insights on its therapeutic use as an immunoregulatory agent.

Authors:  Verônica Coelho; Ana M C Faria
Journal:  Front Immunol       Date:  2012-01-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.